6
Views
6
CrossRef citations to date
0
Altmetric
Original Paper

Short-term survival advantage after plasma exchange in the treatment of acute on chronic liver failure or acute liver failure

, , , , &
Pages 93-99 | Published online: 30 Dec 2011
 

Abstract

Aim: To investigate the efficacy of plasma exchange (PE) in the treatment of patients with acute on chronic or acute liver failure.

Methods: We retrospectively compared the treatment responses of PE and conservative care in patients with acute liver failure from 1998 to 2003. Thirty-two patients treated using supportive care only were enrolled as the control group. The sequential liver biochemical tests, consciousness levels, and survival rates were analyzed.

Results: There were no significant differences between the PE and control groups in terms of age, gender, underlying liver disease, grading of hepatic encephalopathy, levels of albumin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), prothrombin time (PT), activated partial thromboplastin time (aPTT), and total bilirubin. The number of days of survival for the PE group was significantly higher than that of the control group (17.63±1.86 days vs. 8.69±0.86 days, respectively; p<0.05). However, the survival rate was not meaningfully different between the groups (66.7% vs. 59.4%). Transient improvement of hyperbilirubinemia and encephalopathy grade was noted in the PE group compared with the control group.

Conclusions: The short-term outcome was better with PE, suggesting perhaps a temporary improvement which would only be of benefit whilst awaiting liver transplantation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.